This inventor holds 3 USPTO granted patents and 1 EPO patent. Top assignees: Solvay Pharmaceuticals, Gmbh, Regents of the University of Minnesota. Active years: 2000-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2000-2024
Title: Kelley F Kitto: Innovator in Pain Management
Introduction
Kelley F Kitto is a notable inventor based in Minneapolis, MN (US), recognized for his contributions to the field of pain management. With a total of 3 patents, Kitto has focused on developing innovative solutions for chronic pain and opioid addiction.
Latest Patents
Kitto's latest patents include significant advancements in analgesic and anti-addictive compositions. One of his inventions, titled "Analgesic and anti-addictive compositions for treatment of chronic pain and opioid addiction," provides a compound of formula I and its various forms, including stereoisomers and pharmaceutically acceptable salts. This invention outlines pharmaceutical compositions and methods for using these compounds as therapeutic agents for pain-related disorders. Another patent, "Analgesic composition and method for using same," describes a pharmaceutical analgesic composition that combines an opioid analgesic agent with moxonidine, a non-opioid agent, to produce effective analgesia in mammals.
Career Highlights
Throughout his career, Kelley F Kitto has worked with reputable organizations, including Solvay Pharmaceuticals and the University of Minnesota. His work has significantly impacted the development of new therapeutic agents aimed at alleviating pain and addressing opioid addiction.
Collaborations
Kitto has collaborated with notable colleagues, including Carolyn A Fairbanks and George L Wilcox, contributing to the advancement of research in his field.
Conclusion
Kelley F Kitto's innovative work in pain management and opioid addiction treatment showcases his dedication to improving healthcare solutions. His patents reflect a commitment to developing effective therapies that address critical health issues.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile